Köninger, Angela
Mathan, Annette
Mach, Pawel
Frank, Mirjam
Schmidt, Boerge
Schleussner, Ekkehard
Kimmig, Rainer
Gellhaus, Alexandra
Dieplinger, Hans http://orcid.org/0000-0002-4484-8471
Funding for this research was provided by:
Austrian Science Fund (P19969-B11)
Universität Duisburg-Essen
Article History
Received: 23 October 2017
Accepted: 2 March 2018
First Online: 27 March 2018
Ethics approval and consent to participate
: All women provided written informed consent. The study was approved by the local research ethics committee of the University Hospital Essen, Germany (number 125212-BO).
: not applicable
: Dr. Dieplinger is owner and shareholder of Vitateq Biotechnology GmbH, a spin-off company of the Medical University of Innsbruck, holding several patents related to research described in this article. All other authors disclose no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.